AI Engines For more Details: Perplexity Kagi Labs You
Allergic Reactions: Sulfites are known to cause allergic reactions in some individuals, particularly those with sulfite sensitivity or sulfite allergy. Symptoms of sulfite allergy may include hives, itching, flushing, swelling (angioedema), wheezing, difficulty breathing (bronchospasm), asthma exacerbations, gastrointestinal upset (nausea, vomiting, diarrhea), and anaphylaxis (a severe, life-threatening allergic reaction).
Asthma: Sulfite sensitivity is more common in individuals with asthma, and exposure to sulfites can trigger asthma symptoms such as wheezing, chest tightness, coughing, and shortness of breath. Sulfite-induced asthma is characterized by bronchospasm and airway inflammation, which can be severe and require medical intervention.
Urticaria (Hives) and Angioedema: Sulfites have been implicated in the development of urticaria (hives) and angioedema (swelling beneath the skin) in sensitive individuals. These allergic skin reactions may occur shortly after consuming foods or beverages containing sulfites and can range from mild to severe.
Headaches and Migraines: Some individuals report experiencing headaches or migraines after consuming foods or beverages containing sulfites. While the mechanism underlying sulfite-induced headaches is not fully understood, sulfites may act as triggers for certain individuals susceptible to migraines or other types of headaches.
Gastrointestinal Symptoms: Sulfites have been associated with gastrointestinal symptoms such as nausea, vomiting, abdominal pain, and diarrhea in sensitive individuals. These symptoms may occur shortly after consuming sulfite-containing foods or beverages and can vary in severity.
Dermatitis and Skin Reactions: Sulfites may exacerbate or trigger dermatitis (skin inflammation) in individuals with certain skin conditions such as atopic dermatitis (eczema) or contact dermatitis. Skin reactions to sulfites may manifest as itching, redness, rash, or blistering upon contact with sulfite-containing products.
Sulfite-Induced Encephalopathy: Rarely, high doses of sulfites consumed orally or intravenously may lead to sulfite-induced encephalopathy, a neurological condition characterized by confusion, disorientation, seizures, and coma. Sulfite-induced encephalopathy is more commonly observed in individuals with underlying metabolic disorders such as molybdenum cofactor deficiency.
| Rank | Probiotic | Impact |
|---|---|---|
| species | Faecalibacterium prausnitzii | Reduces |
| species | Lacticaseibacillus casei | Reduces |
| species | Lacticaseibacillus rhamnosus | Reduces |
| species | Lactiplantibacillus plantarum | Reduces |
| species | Streptococcus thermophilus | Reduces |
We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.
A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.
We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive X|increases + Y|decrease = Negative.
Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.
| Condition | Positive Impact | Negative Impact | Benefit Ratio Impact |
|---|---|---|---|
| Abdominal Aortic Aneurysm | 0.6 | -0.6 | |
| ADHD | 0.3 | 0.5 | -0.67 |
| Allergic Rhinitis (Hay Fever) | 0.3 | 0.8 | -1.67 |
| Allergies | 1.2 | 1 | 0.2 |
| Allergy to milk products | 0.5 | 0.5 | |
| Alzheimer's disease | 1.1 | 1.9 | -0.73 |
| Amyotrophic lateral sclerosis (ALS) Motor Neuron | 0.5 | 0.5 | 0 |
| Ankylosing spondylitis | 0.3 | 0.3 | |
| Anorexia Nervosa | 0.3 | 1.3 | -3.33 |
| Antiphospholipid syndrome (APS) | 0.9 | 0.9 | |
| Asthma | 0.8 | 1.3 | -0.63 |
| Atherosclerosis | 1 | 0.5 | 1 |
| Atrial fibrillation | 1.4 | 0.5 | 1.8 |
| Autism | 1.9 | 2.3 | -0.21 |
| Autoimmune Disease | 0.3 | 0.7 | -1.33 |
| Barrett esophagus cancer | 0.3 | -0.3 | |
| benign prostatic hyperplasia | 0.5 | -0.5 | |
| Biofilm | 0.3 | 0.3 | |
| Bipolar Disorder | 1 | 1.1 | -0.1 |
| Brain Trauma | 0.3 | 1 | -2.33 |
| Cancer (General) | 2 | -2 | |
| Carcinoma | 0.3 | 0.6 | -1 |
| Celiac Disease | 0.9 | 0.7 | 0.29 |
| Cerebral Palsy | 0.3 | 0.5 | -0.67 |
| Chronic Fatigue Syndrome | 0.9 | 1.3 | -0.44 |
| Chronic Kidney Disease | 0.6 | 0.5 | 0.2 |
| Chronic Obstructive Pulmonary Disease (COPD) | 0.5 | 0.3 | 0.67 |
| Chronic Urticaria (Hives) | 0.3 | 1 | -2.33 |
| Coagulation / Micro clot triggering bacteria | 0.3 | 0.3 | 0 |
| Cognitive Function | 0.8 | 0.8 | 0 |
| Colorectal Cancer | 0.3 | 0.7 | -1.33 |
| Constipation | 0.5 | -0.5 | |
| Coronary artery disease | 0.3 | 1 | -2.33 |
| COVID-19 | 1.3 | 1.5 | -0.15 |
| Crohn's Disease | 1.3 | 1.6 | -0.23 |
| cystic fibrosis | 0.5 | -0.5 | |
| d-lactic acidosis (one form of brain fog) | 1.5 | 1.5 | |
| deep vein thrombosis | 0.5 | -0.5 | |
| Denture Wearers Oral Shifts | 0.3 | 0.3 | |
| Depression | 0.8 | 2.4 | -2 |
| Dermatomyositis | 0.3 | 0.3 | |
| Eczema | 1.3 | 0.3 | 3.33 |
| Endometriosis | 1.3 | 1.3 | |
| Eosinophilic Esophagitis | 0.3 | -0.3 | |
| Epilepsy | 1.3 | 0.5 | 1.6 |
| Fibromyalgia | 1 | -1 | |
| Functional constipation / chronic idiopathic constipation | 0.8 | 0.5 | 0.6 |
| gallstone disease (gsd) | 0.5 | 0.5 | 0 |
| Gastroesophageal reflux disease (Gerd) including Barrett's esophagus | 0.5 | 0.3 | 0.67 |
| Generalized anxiety disorder | 0.3 | 0.8 | -1.67 |
| Glioblastoma | 0.8 | -0.8 | |
| Gout | 0.3 | 0.6 | -1 |
| Graves' disease | 0.8 | -0.8 | |
| Gulf War Syndrome | 0.3 | 0.3 | |
| Halitosis | 0.3 | 0.3 | 0 |
| Hashimoto's thyroiditis | 0.8 | 1 | -0.25 |
| Heart Failure | 0.8 | 1 | -0.25 |
| Hidradenitis Suppurativa | 0.3 | 0.6 | -1 |
| High Histamine/low DAO | 0.5 | 0.5 | 0 |
| hypercholesterolemia (High Cholesterol) | 1 | -1 | |
| hyperglycemia | 0.5 | 0.5 | 0 |
| Hyperlipidemia (High Blood Fats) | 1.1 | -1.1 | |
| hypersomnia | 0.6 | 0.6 | |
| hypertension (High Blood Pressure | 0.9 | 1.3 | -0.44 |
| Hypothyroidism | 0.5 | -0.5 | |
| IgA nephropathy (IgAN) | 0.3 | 0.3 | |
| Inflammatory Bowel Disease | 1.4 | 2.5 | -0.79 |
| Insomnia | 0.3 | 0.8 | -1.67 |
| Intelligence | 0.5 | 0.5 | 0 |
| Intracranial aneurysms | 0.5 | -0.5 | |
| Irritable Bowel Syndrome | 0.8 | 1.5 | -0.88 |
| ischemic stroke | 0.3 | 1 | -2.33 |
| Liver Cirrhosis | 1.4 | 1.4 | 0 |
| Long COVID | 1.6 | 1 | 0.6 |
| Lung Cancer | 1.1 | -1.1 | |
| Lymphoma | 0.8 | -0.8 | |
| Mast Cell Issues / mastitis | 0.3 | 0.3 | |
| ME/CFS with IBS | 0.3 | 1 | -2.33 |
| ME/CFS without IBS | 0.3 | 0.3 | |
| membranous nephropathy | 0.3 | 0.3 | |
| Menopause | 0.3 | 0.5 | -0.67 |
| Metabolic Syndrome | 1.1 | 3 | -1.73 |
| Mood Disorders | 1.3 | 1.9 | -0.46 |
| multiple chemical sensitivity [MCS] | 0.8 | 0.5 | 0.6 |
| Multiple Sclerosis | 0.8 | 2.1 | -1.63 |
| myasthenia gravis | 0.8 | 0.5 | 0.6 |
| neuropathic pain | 0.2 | 1 | -4 |
| Neuropathy (all types) | 0.3 | 1 | -2.33 |
| neuropsychiatric disorders (PANDAS, PANS) | 0.3 | 0.5 | -0.67 |
| Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic | 0.3 | 1 | -2.33 |
| NonCeliac Gluten Sensitivity | 0.5 | -0.5 | |
| Obesity | 1.3 | 2.6 | -1 |
| obsessive-compulsive disorder | 0.8 | 0.8 | 0 |
| Osteoarthritis | 0.3 | 1.3 | -3.33 |
| Osteoporosis | 1 | 0.8 | 0.25 |
| pancreatic cancer | 0.3 | 0.3 | 0 |
| Parkinson's Disease | 1.3 | 2.6 | -1 |
| Polycystic ovary syndrome | 1.4 | 0.8 | 0.75 |
| primary biliary cholangitis | 0.3 | 0.8 | -1.67 |
| Primary sclerosing cholangitis | 0.3 | 1 | -2.33 |
| Psoriasis | 0.8 | 0.8 | |
| rheumatoid arthritis (RA),Spondyloarthritis (SpA) | 0.8 | 1.8 | -1.25 |
| Rosacea | 0.5 | -0.5 | |
| Schizophrenia | 0.3 | 1.3 | -3.33 |
| scoliosis | 0.6 | 0.6 | |
| Sjögren syndrome | 1.3 | 1 | 0.3 |
| Sleep Apnea | 0.5 | -0.5 | |
| Small Intestinal Bacterial Overgrowth (SIBO) | 0.3 | 0.3 | |
| Stress / posttraumatic stress disorder | 1.5 | -1.5 | |
| Systemic Lupus Erythematosus | 0.3 | 1.1 | -2.67 |
| Tic Disorder | 0.8 | 0.8 | |
| Tourette syndrome | 0.3 | 0.3 | |
| Type 1 Diabetes | 0.8 | 1.9 | -1.37 |
| Type 2 Diabetes | 0.8 | 1.9 | -1.37 |
| Ulcerative colitis | 1.9 | 1.5 | 0.27 |
| Unhealthy Ageing | 0.3 | 1.1 | -2.67 |
| Vitiligo | 0.3 | 0.3 |
